14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Nov 20, 2023 Buy 61 248 Weinstein Robert Stock Option (Right to Buy)
Nov 20, 2023 Buy 61 248 Walker Wayne Remell Stock Option (Right to Buy)
Nov 20, 2023 Buy 85 000 Trujillo Carlos Stock Option (Right to Buy)
Nov 20, 2023 Buy 170 000 Silverman Joshua Stock Option (Right to Buy)
Nov 20, 2023 Buy 61 248 Schechter Jonathan Stock Option (Right to Buy)
Nov 20, 2023 Buy 61 248 Abecassis Michael M Stock Option (Right to Buy)
Dec 28, 2022 Buy 0 Walker Wayne Remell
Dec 28, 2022 Buy 0 Walker Wayne Remell
Dec 28, 2022 Buy 125 000 Farb Daniel Stuart Stock Option (Right to Buy)
Dec 28, 2022 Buy 125 000 Allen Daniel Stock Option (Right to Buy)
Nov 14, 2022 Buy 0 Weinstein Robert
Nov 14, 2022 Buy 0 Weinstein Robert
Aug 15, 2022 Buy 0 Allen Daniel Common Shares
Aug 15, 2022 Buy 0 Schechter Jonathan Common Stock
Aug 15, 2022 Buy 0 Stover Jack E
Aug 15, 2022 Buy 0 Silverman Joshua Common Stock
Aug 15, 2022 Buy 0 Farb Daniel Stuart Common Stock
Aug 15, 2022 Buy 795 000 Farb Daniel Stuart Stock Option (short put)
Mar 31, 2022 Buy 0 Loehr Matthias Common Stock
Aug 10, 2021 Buy 0 Trujillo Carlos Common Stock
Aug 10, 2021 Buy 0 Waggoner Kenneth L. Common Stock
Aug 10, 2021 Buy 0 Yuen Thomas C K Common Stock
Aug 10, 2021 Buy 0 Crabtree Gerald W Common Stock
Aug 10, 2021 Buy 0 Liquard Thomas Common Stock
Aug 10, 2021 Buy 0 Tong Raymond Cf Common Stock
Aug 10, 2021 Buy 0 Abecassis Michael M Common Stock
Aug 10, 2021 Buy 0 Abecassis Michael M Common Stock
Jul 01, 2021 Buy 334 Abecassis Michael M Stock Option (right to buy)
May 01, 2021 Buy 334 Yuen Thomas C K Stock Option (right to buy)
May 01, 2021 Buy 334 Liquard Thomas Stock Option (right to buy)
Jan 01, 2021 Buy 2 000 Trujillo Carlos Stock Option (right to buy)
Jan 01, 2021 Buy 3 000 Waggoner Kenneth L. Stock Option (right to buy)
Jan 01, 2021 Buy 1 000 Crabtree Gerald W Stock Option (right to buy)
Oct 09, 2020 Buy 334 Tong Raymond Cf Stock Option (right to buy)
Jul 01, 2020 Buy 334 Abecassis Michael M Stock Option (right to buy)
May 01, 2020 Buy 334 Yuen Thomas C K Stock Option (right to buy)
May 01, 2020 Buy 334 Liquard Thomas Stock Option (right to buy)
Jan 02, 2020 Buy 2 000 Trujillo Carlos Stock Option (right to buy)
Jan 02, 2020 Buy 3 000 Waggoner Kenneth L. Stock Option (right to buy)
Jan 02, 2020 Buy 1 000 Crabtree Gerald W Stock Option (right to buy)
Oct 09, 2019 Buy 334 Tong Raymond Cf Stock Option (right to buy)
Jul 01, 2019 Buy 334 Abecassis Michael M Stock Option (right to buy)
May 01, 2019 Buy 334 Yuen Thomas C K Stock Option (right to buy)
May 01, 2019 Buy 334 Liquard Thomas Stock Option (right to buy)
Mar 20, 2019 Buy 2 000 Trujillo Carlos Stock Option (right to buy)
Mar 20, 2019 Buy 3 000 Waggoner Kenneth L. Stock Option (right to buy)
Mar 20, 2019 Buy 1 000 Crabtree Gerald W Stock Option (right to buy)
Oct 09, 2018 Buy 334 Tong Raymond Cf Stock Option (right to buy)
Jul 01, 2018 Buy 334 Abecassis Michael M Stock Option (right to buy)
May 01, 2018 Buy 334 Yuen Thomas C K Stock Option (right to buy)
May 01, 2018 Buy 334 Liquard Thomas Stock Option (right to buy)
Jan 01, 2018 Buy 2 000 Trujillo Carlos Stock Option (right to buy)
Jan 01, 2018 Buy 3 000 Waggoner Kenneth L. Stock Option (right to buy)
Jan 01, 2018 Buy 1 000 Crabtree Gerald W Stock Option (right to buy)
Oct 09, 2017 Buy 334 Tong Raymond Cf Stock Option (right to buy)
Jul 03, 2017 Buy 334 Yuen Thomas C K Stock Option (right to buy)
Jul 03, 2017 Buy 167 Liquard Thomas Stock Option (right to buy)
Jul 03, 2017 Buy 334 Abecassis Michael M Stock Option (right to buy)
Jul 03, 2017 Buy 800 Abecassis Michael M Stock Option (right to buy)
Mar 09, 2017 Buy 2 000 Trujillo Carlos Stock Option (right to buy)
Mar 09, 2017 Buy 3 000 Waggoner Kenneth L. Stock Option (right to buy)
Mar 09, 2017 Buy 1 000 Crabtree Gerald W Stock Option (right to buy)
Mar 09, 2017 Buy 167 Liquard Thomas Stock Option (right to buy)
Mar 17, 2009 Buy 0 Schmieg Martin Common stock, par value $0.0001
Mar 17, 2009 Buy 0 Barnes Marylew Common stock, par value $0.0001
INSIDER POWER
77.601
Last 65 transactions
Buy: 1 582 138 | Sell: 0 (Shares)

Based on the 65 latest insides trades, we have calculated the insider power to be positive at a ratio of 77.601.

In total, the insiders bought 1 582 138 and sold 0 PMCB shares in the last 65 trades.

Click to get the best stock tips daily for free!

About Pharmacyt Biotch

Pharmacyt Biotch PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer and diabetes in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable non-metastatic pancreatic cancer, as well as diabetes. The company is developin... PMCB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT